San Antonio—A new HER-targeted antibody, pertuzumab (Omnitarg, Roche), is poised to alter the treatment landscape of patients with HER2-positive metastatic breast cancer (MBC).read more
San Antonio—A growing body of evidence backs the contention that bisphosphonates can improve survival in breast cancer patients with low estrogen levels. The results of three studies of bisphosphonates in this setting ...read more
New Orleans—The American Medical Association’s (AMA) House of Delegates has introduced a policy backing existing measures to address what it is calling the “national public health emergency” of drug ...read more
This review discusses the changing epidemiology, transmission, risk ...
This review focuses on the management of mucositis affecting the ...